Aksoy, SavaşKanat, ÖzkanTunca, BerrinErtaş, HülyaUğraş, NesrinÖztürk, ErmanYılmazlar, TuncayÇeçener, GülşahEgeli, ÜnalYerci, Ömer2024-07-262024-07-262018-03-010923-7534https://hdl.handle.net/11452/43460Bu çalışma, 05-07, Mart 2018 tarihlerinde Paris[Fransa]’da düzenlenen International Congress on Targeted Anticancer Therapies (TAT) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineOncologyMicrorna dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeuticsMeeting Abstract000427179500101291569-8041